These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10584767)

  • 1. A dose-outcome analysis of risperidone.
    Love RC; Conley RR; Kelly DL; Bartko JJ
    J Clin Psychiatry; 1999 Nov; 60(11):771-5. PubMed ID: 10584767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone dosing pattern and clinical outcome in psychosis: an analysis of 1713 cases.
    Kim CY; Shin YW; Joo YH; Hong JP; Lee GH; Choi SK
    J Clin Psychiatry; 2005 Jul; 66(7):887-93. PubMed ID: 16013904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.
    Feifel D; Moutier CY; Perry W
    J Clin Psychiatry; 2000 Dec; 61(12):909-11. PubMed ID: 11206594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
    Conley RR; Love RC; Kelly DL; Bartko JJ
    Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients.
    Javitt DC; Cienfuegos A; Miniati M; Silipo G; Levine J; Allingham BH; Robinson J
    J Clin Psychiatry; 2002 Jul; 63(7):585-90. PubMed ID: 12143914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
    Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
    J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal dosing with risperidone: updated recommendations.
    Williams R
    J Clin Psychiatry; 2001 Apr; 62(4):282-9. PubMed ID: 11379843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturalistic outcome study of risperidone treatment among hospital patients.
    Negrón AE; Leiderman EA; Parkadavil M; Cienfuegos A; Javitt DC
    Psychiatr Serv; 1996 Oct; 47(10):1118-20. PubMed ID: 8890343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in the recommended dosing schedule for risperidone.
    Luchins DJ; Klass D; Hanrahan P; Malan R; Harris J
    Am J Psychiatry; 1998 Mar; 155(3):365-6. PubMed ID: 9501746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
    Yoshimura Y; Takeda T; Kishi Y; Harada T; Nomura A; Washida K; Yoshimura B; Sato K; Yada Y; Aoki S
    J Clin Psychopharmacol; 2017 Jun; 37(3):296-301. PubMed ID: 28306616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidone.
    Leal A; Rosillon D; Mehnert A; Jarema M; Remington G
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):811-6. PubMed ID: 15386706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
    Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
    Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.